CD274 and lung carcinoma: Even though immunotherapy aims to support the activation of the immune system [25], there are no published reports evaluating the role of sCD8 protein (i.e., a molecule clearly linked with the immune system) in the successful treatment with anti-PD-1/PD-L1 agents, neither in lung cancer nor in other malignancies.